Universal-Beteiligungs- und Servicegesellschaft’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Buy
204,556
+12,282
+6% +$837K 0.02% 474
2026
Q1
$12.4M Sell
192,274
-9,875
-5% -$696K 0.02% 535
2025
Q4
$13.6M Buy
202,149
+6,690
+3% +$450K 0.02% 502
2025
Q3
$14.3M Sell
195,459
-30,534
-14% -$2.03M 0.02% 488
2025
Q2
$11.8M Sell
225,993
-17,859
-7% -$1.02M 0.02% 527
2025
Q1
$15.6M Buy
243,852
+34,028
+16% +$1.98M 0.03% 427
2024
Q4
$10M Buy
+209,824
New +$10.8M 0.02% 543

Other funds holding HALO

Universal-Beteiligungs- und Servicegesellschaft's HALO Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Halozyme (HALO) stake by 6.4% in Q2 2026, buying an estimated $837K and bringing the position to 204,556 shares worth $16M. The position accounts for 0.02% of the portfolio, ranked #474.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 204,556 shares of Halozyme worth $16M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 12,282 Halozyme shares in Q2 2026, an estimated $837K.
  • Halozyme made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #474 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.